Modulation of T cell function by combination of epitope specific and low dose anticytokine therapy controls autoimmune arthritis.
Innate and adaptive immunity contribute to the pathogenesis of autoimmune arthritis by generating and maintaining inflammation, which leads to tissue damage. Current biological therapies target innate immunity, eminently by interfering with single pro-inflammatory cytokine pathways. This approach ha...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2006-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC1762388?pdf=render |